Cargando…

Virus detection via programmable Type III-A CRISPR-Cas systems

Among the currently available virus detection assays, those based on the programmable CRISPR-Cas enzymes have the advantage of rapid reporting and high sensitivity without the requirement of thermocyclers. Type III-A CRISPR-Cas system is a multi-component and multipronged immune effector, activated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sridhara, Sagar, Goswami, Hemant N., Whyms, Charlisa, Dennis, Jonathan H., Li, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476571/ https://www.ncbi.nlm.nih.gov/pubmed/34580296 http://dx.doi.org/10.1038/s41467-021-25977-7

Ejemplares similares

Structural principles of CRISPR-Cas enzymes used in nucleic acid detection
por: Das, Anuska, et al.
Publicado: (2022)

Structural and biochemical characterization of in vivo assembled Lactococcus lactis CRISPR-Csm complex
por: Sridhara, Sagar, et al.
Publicado: (2022)

Programmable type III-A CRISPR-Cas DNA targeting modules
por: Ichikawa, H. Travis, et al.
Publicado: (2017)

Programmable RNA detection with CRISPR-Cas12a
por: Rananaware, Santosh R., et al.
Publicado: (2023)

Programmable RNA detection with CRISPR-Cas12a
por: Rananaware, Santosh R., et al.
Publicado: (2023)

Programmable RNA detection with CRISPR-Cas12a
por: Rananaware, Santosh R., et al.
Publicado: (2023)

Molecular mechanism of active Cas7-11 in processing CRISPR RNA and interfering target RNA
por: Goswami, Hemant N, et al.
Publicado: (2022)

Programmable CRISPR‐Cas transcriptional activation in bacteria
por: Ho, Hsing‐I, et al.
Publicado: (2020)

Harnessing Type I and Type III CRISPR-Cas systems for genome editing
por: Li, Yingjun, et al.
Publicado: (2016)

The Cyclic Oligoadenylate Signaling Pathway of Type III CRISPR-Cas Systems
por: Huang, Fengtao, et al.
Publicado: (2021)

Critical roles for ‘housekeeping’ nucleases in type III CRISPR-Cas immunity
por: Chou-Zheng, Lucy, et al.
Publicado: (2022)

Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression
por: Luo, Michelle L., et al.
Publicado: (2015)

Programmable RNA recognition and cleavage by CRISPR/Cas9
por: O’Connell, Mitchell R., et al.
Publicado: (2014)

Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble
por: Liu, Tina Y., et al.
Publicado: (2019)

Targeted RNA Knockdown by a Type III CRISPR-Cas Complex in Zebrafish
por: Fricke, Thomas, et al.
Publicado: (2020)

Unique properties of spacer acquisition by the type III-A CRISPR-Cas system
por: Zhang, Xinfu, et al.
Publicado: (2021)

The Involvement of Mycobacterium Type III-A CRISPR-Cas System in Oxidative Stress
por: Yang, Fan, et al.
Publicado: (2021)

Adaptation by Type III CRISPR-Cas Systems: Breakthrough Findings and Open Questions
por: Zhang, Xinfu, et al.
Publicado: (2022)

The diverse arsenal of type III CRISPR–Cas-associated CARF and SAVED effectors
por: Steens, Jurre A., et al.
Publicado: (2022)

Target RNA capture and cleavage by the Cmr type III-B CRISPR–Cas effector complex
por: Hale, Caryn R., et al.
Publicado: (2014)

CRISPR-Cas based virus detection: Recent advances and perspectives
por: Yin, Lijuan, et al.
Publicado: (2021)

CRISPR-Cas12a-based detection of monkeypox virus
por: Sui, Yutong, et al.
Publicado: (2022)

The biology and type I/III hybrid nature of type I-D CRISPR–Cas systems
por: McBride, Tess M., et al.
Publicado: (2023)

Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis
por: Elmore, Joshua R., et al.
Publicado: (2013)

Programmable Biosensors Based on RNA-Guided CRISPR/Cas Endonuclease
por: Liu, Xiaolong, et al.
Publicado: (2022)

RNA-activated DNA cleavage by the Type III-B CRISPR–Cas effector complex
por: Estrella, Michael A., et al.
Publicado: (2016)

On the Origin and Evolutionary Relationships of the Reverse Transcriptases Associated With Type III CRISPR-Cas Systems
por: Toro, Nicolás, et al.
Publicado: (2018)

Type III CRISPR-Cas Systems: Deciphering the Most Complex Prokaryotic Immune System
por: Kolesnik, Matvey V., et al.
Publicado: (2021)

Target RNA-guided protease activity in type III-E CRISPR–Cas system
por: Wang, Xiaoshen, et al.
Publicado: (2022)

Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system
por: Elmore, Joshua R., et al.
Publicado: (2016)

DNA targeting by subtype I-D CRISPR–Cas shows type I and type III features
por: Lin, Jinzhong, et al.
Publicado: (2020)

Detection of Infectious Viruses Using CRISPR-Cas12-Based Assay
por: Talwar, Chandana S., et al.
Publicado: (2021)

Pathogen detection in the CRISPR–Cas era
por: Sashital, Dipali G.
Publicado: (2018)

Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases
por: Bikard, David, et al.
Publicado: (2014)

DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle
por: Mikheikin, Andrey, et al.
Publicado: (2017)

Integrating CRISPR/Cas systems with programmable DNA nanostructures for delivery and beyond
por: Piskunen, Petteri, et al.
Publicado: (2022)

An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover
por: Liu, Jilin, et al.
Publicado: (2023)

Spacer acquisition by Type III CRISPR–Cas system during bacteriophage infection of Thermus thermophilus
por: Artamonova, Daria, et al.
Publicado: (2020)

Different modes of spacer acquisition by the Staphylococcus epidermidis type III-A CRISPR-Cas system
por: Aviram, Naama, et al.
Publicado: (2022)

Structural basis of cyclic oligoadenylate degradation by ancillary Type III CRISPR-Cas ring nucleases
por: Molina, Rafael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fmdsq6kr098sg072tob9kimus4